CIRILLO, PLINIO
 Distribuzione geografica
Continente #
AS - Asia 6.768
EU - Europa 5.303
NA - Nord America 4.912
SA - Sud America 1.072
AF - Africa 176
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.243
Nazione #
US - Stati Uniti d'America 4.696
SG - Singapore 3.905
RU - Federazione Russa 2.626
CN - Cina 1.335
BR - Brasile 877
IT - Italia 857
HK - Hong Kong 706
VN - Vietnam 446
DE - Germania 361
FI - Finlandia 267
NL - Olanda 263
IE - Irlanda 195
SE - Svezia 154
UA - Ucraina 136
CA - Canada 134
GB - Regno Unito 122
FR - Francia 89
AR - Argentina 79
IN - India 70
ZA - Sudafrica 59
MX - Messico 52
KR - Corea 44
PL - Polonia 42
EC - Ecuador 41
BD - Bangladesh 38
CI - Costa d'Avorio 37
AT - Austria 34
ID - Indonesia 34
ES - Italia 31
JP - Giappone 30
BG - Bulgaria 28
IQ - Iraq 25
CO - Colombia 23
TR - Turchia 22
PY - Paraguay 18
MA - Marocco 17
PK - Pakistan 15
BE - Belgio 14
CZ - Repubblica Ceca 14
VE - Venezuela 13
LT - Lituania 12
EG - Egitto 11
UZ - Uzbekistan 11
CH - Svizzera 10
IR - Iran 10
KE - Kenya 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
RO - Romania 8
AL - Albania 7
TN - Tunisia 7
BH - Bahrain 6
PT - Portogallo 6
DO - Repubblica Dominicana 5
GT - Guatemala 5
JM - Giamaica 5
JO - Giordania 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
PE - Perù 5
SA - Arabia Saudita 5
UY - Uruguay 5
DZ - Algeria 4
IL - Israele 4
MY - Malesia 4
OM - Oman 4
TW - Taiwan 4
AO - Angola 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
BW - Botswana 3
ET - Etiopia 3
GA - Gabon 3
MD - Moldavia 3
NG - Nigeria 3
NI - Nicaragua 3
PH - Filippine 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AU - Australia 2
BO - Bolivia 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
GE - Georgia 2
GH - Ghana 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
ME - Montenegro 2
MK - Macedonia 2
MZ - Mozambico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
YE - Yemen 2
BS - Bahamas 1
Totale 18.208
Città #
Singapore 1.710
Hong Kong 706
Moscow 686
Chandler 538
Beijing 331
Santa Clara 306
Ashburn 277
Hefei 232
Millbury 228
Amsterdam 227
Princeton 200
Nanjing 181
Ho Chi Minh City 168
Naples 166
Los Angeles 164
Jacksonville 148
Boston 142
Buffalo 118
Munich 113
Napoli 101
Wilmington 97
Hanoi 96
Ottawa 82
Redondo Beach 82
The Dalles 75
São Paulo 70
New York 68
Des Moines 66
Nanchang 49
Dallas 46
Lawrence 41
Seoul 41
Seattle 37
Helsinki 36
Dublin 35
Hebei 35
Turku 33
Rio de Janeiro 32
Rome 32
Shenyang 32
Warsaw 31
Denver 29
Norwalk 29
Nuremberg 29
Milan 28
Frankfurt am Main 26
Tokyo 26
Belo Horizonte 25
Orem 25
Sofia 25
Johannesburg 24
Mexico City 24
Tianjin 24
Atlanta 23
Jiaxing 23
Kronberg 23
Brooklyn 22
Houston 22
London 21
Afragola 20
Dong Ket 20
Haiphong 20
Montreal 20
Falls Church 18
Kunming 18
Boardman 17
Chennai 17
Poplar 17
Changsha 16
Da Nang 16
San Francisco 16
Stockholm 16
Vienna 16
Augusta 15
Brasília 15
Chicago 15
Quito 15
Toronto 14
Biên Hòa 12
Redwood City 12
Salvador 12
Woodbridge 12
Ann Arbor 11
Guarulhos 11
Hangzhou 11
Pune 11
Campinas 10
Dhaka 10
Guayaquil 10
Hải Dương 10
Manchester 10
Nairobi 10
New Delhi 10
Redmond 10
Ribeirão Preto 10
San Jose 10
Thái Bình 10
Brno 9
Buenos Aires 9
Fairfield 9
Totale 8.856
Nome #
True double bifurcation lesions: new application of the self-expandable Axxess stent and review of literature with dedicated bifurcation devices 158
Moderate to severe mitral regurgitation in patients undergoing trancatheter aortic valve replacement: a meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,933 patients 133
Protective role of chronic ubiquinone administration on acute cardiac oxidative stress. 121
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion 120
B1-Adrenergic Receptor and Sphingosine-1-Phosphate Receptor 1 (S1PR1) Reciprocal Downregulation Influences Cardiac Hypertrophic Response and Progression to Heart Failure: Protective Role of S1PR1 Cardiac Gene Therapy 116
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 115
Human heart shifts from IGF-1 production to utilization with chronic heart failure 113
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 111
Diastolic dysfunction reduces stroke volume during daily's life activities in patients with severe aortic stenosis. 111
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 110
Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome 109
Quantitative detection of inducible ischemia during dobutamine stress by speckle tracking echocardiography: A dream comes true 109
Predictors of adherence to composite therapy after acute coronary syndromes 109
Pregnancy-associated plasma protein-A promotes TF procoagulant activity in human endothelial cells by Akt–NF-κB axis 108
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 107
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale : The FABOLUS FASTER Trial 107
Meta-Analysis of Mortality Outcomes and Mitral Regurgitation Evolution in 4,839 Patients Having Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. 106
Extent of cardiac damage and mortality in patients undergoing transcatheter aortic valve implantation 105
Abluminal-Coated Drug-Eluting Bifurcation-Dedicated Stent for the Treatment of Tibioperoneal Bifurcation 104
Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-κB 102
Correction to: Human heart shifts from IGF-1 production to utilization with chronic heart failure (Endocrine, (2019), 65, 3, (714-716), 10.1007/s12020-019-01993-y) 102
Anorexia nervosa-related cardiopathy in children with physical instability: prevalence, echocardiographic characteristics and reversibility at mid-term follow-up 102
A New Approach to Percutaneous Coronary Revascularization in Patients Requiring Undeferrable Non Cardiac Surgery. 101
Low-Dose Ticagrelor in Patients With High Ischemic Risk and Previous Myocardial Infarction: A Multicenter Prospective Real-World Observational Study 101
Quinacrine as a Novel Anti-Restenotic and Anti-Thrombotic Drug for Coronary Artery Interventions. 100
Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique 99
L'aumento dei livelli di high mobility group box-1 protein (HMGB1) è associato a riduzione dei parametri cardiopolmonari ed ecocardiografici dopo infarto miocardico acuto 99
Low-dose quinacrine reduces vascular restenosis without affecting re-endothelialization 99
Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation 97
Very late bioresorbable scaffold thrombosis and reoccurrence of dissection two years later chronic total occlusion recanalization of the left anterior descending artery 97
Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK Study 97
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 96
Angiographic improvement in STEMI reperfusion: a single centre experience 96
Accuracy of global and regional longitudinal strain at peak of dobutamine stress echocardiography to detect significant coronary artery disease 96
Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis 95
Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction 95
Changes and prognostic impact of noninvasive myocardial work indices in patients undergoing transcatheter aortic valve implantation 94
La leptina induce la produzione di Proteina C-Reattiva in cellule endoteliali coronariche umane. 94
Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction 94
Prevenzione della restenosi e della trombosi intrastent: ruolo del derivato acridinico quinacrina 94
The pitfalls of managing thrombosis of an Absorb?-treated bifurcation 94
Fructose induces prothrombotic phenotype in human endothelial cells: A new role for “added sugar” in cardio-metabolic risk 94
La resistina è un’ adipocitochina in grado di indurre l’ espressione del fattore tissutale da parte di cellule endoteliali prelevate da arterie coronariche umane. 93
Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis? 93
Ruolo del derivato acridinico Quinacrina nella prevenzione della restenosi e della trombosi intrastent. 92
Meta-Analysis of Effect of Body Mass Index on Outcomes After Transcatheter Aortic Valve Implantation 92
Effects of Hypobaric Hypoxia on Endothelial Function and Adiponectin Levels in Airforce Aviators 92
Vitamin D Inhibits IL-6 Pro-Atherothrombotic Effects in Human Endothelial Cells: A Potential Mechanism for Protection against COVID-19 Infection? 92
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 91
Relationship between Pregnancy-associated Plasma Protein-A and tissue factor levels in the coronary circulation of patients with acute coronary syndrome 91
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. 90
Recombinant Human, Active Site-Blocked Factor VIIa Reduces Infarct Size And The No-Reflow Phenomenon In A Rabbit Model Of Myocardial Ischemia And Reperfusion. 90
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 90
Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1 90
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry 90
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial 90
Management of Intraventricular Gradient in Patients With Aortic Stenosis 89
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions 89
Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 89
Long term combination treatment for severe idiopathic pulmonary arterial hypertension 89
Pharmacotherapeutic Considerations for the Use of Prasugrel and Ticagrelor to Reduce Stent Thrombosis in Patients With Acute Coronary Syndrome. 89
Percutaneous approach to treatment of coronary disease in a patient with uremic cardiomyopathy. 88
Quinacrine as a novel drug in the prevention of in-stent restenosis and thrombosis. 88
No-Reflow Phenomenon: Pathophysiology, Diagnosis, Prevention, and Treatment. A Review of the Current Literature and Future Perspectives. 88
Reperfusion Correlates and Clinical Outcomes of Right Ventricular Dysfunction in Patients With Inferior ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention 88
Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention 87
Pregnancy-Associated Plasma Protein-A and its Role in Cardiovascular Disease. Biology, experimental/clinical evidences and potential therapeutic approaches 87
Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with st-segment-elevation myocardial infarction: Primary results of the FABOLUS-FASTER trial 87
Effects of colchicine on tissue factor in oxLDL-activated T-lymphocytes 87
Acquired Left Coronary Artery Fistula Draining to Cardiac Vein System after Acute Myocardial Infarction Revealed by CT-Scan. 86
Independent association of longitudinal strain of left anterior ascending artery territory and TIMI frame count after acute anterior STEMI 86
A short burst of oxygen radicals at reflow induces sustained release of oxidized glutathione from postischemic hearts. 85
Vitamin D inhibits Tissue Factor and CAMs expression in oxidized low-density lipoproteins-treated human endothelial cells by modulating NF-κB pathway 85
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries. 84
Treatment of residual type A aortic dissection with implantation of the Djumbodis system: is purely endovascular treatment becoming a reality? 84
Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel 83
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study 82
Long-Lasting Antithrombotic Effects Of A Single Dose Of Human Recombinant, Active Site-Blocked Factor VII: Insights Into Possible Mechanism(S) Of Action. 82
La Visfatina induce la trascrizione e l' espressione di Tissue Factor attivo in cellule endoteliali coronariche umane in coltura. 82
Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry 82
Induction of tissue factor in the arterial wall during recurrent thrombus formation 81
Indicazioni alla coronarografia: linee guida 81
Exercise training prevents left ventricular remodeling, reduces NT-pro-BNP and improves cardiovascular function in patients with acute myocardial infarction and moderate left ventricular dysfunction 81
Mid-term outcomes after percutaneous interventions in coronary bifurcations 81
Comparative effectiveness of Cangrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational investigation from the M.O.Ca. registry 80
Latent left ventricular ouflow tract obstruction induced by abnormal hypertrophic papillary muscle caused myocardial ischemia. 80
Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1 80
Local cytokine production in patients with Acute Coronary Syndromes: A look into the eye of the perfect (cytokine) storm 80
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses 79
A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions 79
Pro-atherothrombotic effects of leptin in human coronary endothelial cells. 77
High Mobility Group Box-1 protein as early marker of heart failure in patients with acute myocardial infarction. 76
High Mobility Group Box-1 protein as early marker of heart failure in patients with acute myocardial infarction 76
Von Willebrand Factor and cardiovascular disease: from a biochemical marker to an attractive therapeutic target 76
Adipokines, Vascular Wall, and Cardiovascular Disease: A Focused Overview of the Role of Adipokines in the Pathophysiology of Cardiovascular Disease 75
Nicotine induces Tissue Factor expression in cultured endothelial and smooth muscle cells. 75
Induction of tissue factor in the arterial wall during recurrent thrombus formation 75
Effects of Exercise Training on High-Mobility Group Box-1 Levels After Acute Myocardial Infarction 75
Clinical use of cangrelor: a real world multicenter experience from South Italy Insights from the M.O.Ca. registry 75
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI 74
Totale 9.308
Categoria #
all - tutte 66.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021359 0 0 0 0 0 106 24 18 72 19 85 35
2021/20221.156 18 5 15 9 12 79 20 45 240 25 135 553
2022/20231.475 251 96 32 108 185 133 11 114 199 237 80 29
2023/2024962 45 169 107 59 33 72 27 84 37 13 204 112
2024/20256.334 334 511 16 50 179 259 693 409 605 629 2.111 538
2025/20266.582 1.238 879 1.159 1.070 2.009 227 0 0 0 0 0 0
Totale 18.555